Open access
Open access
Powered by Google Translator Translator

General Gynecology

Study: Despite clinical practice guidelines recommending cervical cancer screening every 3 years or cotesting with HPV and cytologic testing every 5 years, many women get tested much more often

3 May, 2021 | 05:19h | UTC

Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014 – JAMA Network Open

 


AHA Scientific Statement: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormonal therapies

29 Apr, 2021 | 08:33h | UTC

Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association – Circulation: Genomic and Precision Medicine

News release: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormones – American Heart Association

Top Things to Know: Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System – American Heart Association

Commentaries: Hormonal Therapy for Breast and Prostate Cancer: Lessons and Opportunities – American Heart Association AND Hormonal Based Therapies in the Treatment of Breast and Prostate Cancer – balancing the risks! – American Heart Association AND Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement – TCTMD AND Closely Monitor Heart Health in Cancer Patients Who Get Hormonal Therapies: AHA – HealthDay

 


M-A: Lidocaine lubricant jelly does not reduce pain perception during female urethral catheterization

27 Apr, 2021 | 09:11h | UTC

Lidocaine lubricant jelly does not reduce pain perception during female urethral catheterization: A systematic review with meta‐analysis and trial sequential analysis – The International Journal of Clinical Practice (link to abstract – $ for full-text)

 


RCT: No benefit from immune checkpoint inhibitors in newly diagnosed stage III or IV ovarian cancer

25 Apr, 2021 | 20:57h | UTC

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39) – Journal of Clinical Oncology

Editorial: Immune Checkpoint Inhibitors in Ovarian Cancer: Can We Bridge the Gap Between IMagynation and Reality?

 


Guideline: Prevention of Positioning Injuries During Gynecologic Surgery

25 Apr, 2021 | 20:50h | UTC

The Prevention of Positioning Injuries During Gynecologic Surgery. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/077, October 2020) – Geburtshilfe und Frauenheilkunde

 


Guideline: Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis)

25 Apr, 2021 | 20:47h | UTC

Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020) – Geburtshilfe und Frauenheilkunde

 


Guideline: Diagnosis and Treatment of Endometriosis

25 Apr, 2021 | 20:46h | UTC

Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020) – Geburtshilfe und Frauenheilkunde

 


RCT: Treatments for vulnerable older adult women with ovarian cancer compared

23 Apr, 2021 | 08:15h | UTC

Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A Randomized Clinical Trial – JAMA Oncology (free for a limited period)

Editorial: Vulnerable Older Adults With Ovarian Cancer—Time to Stop Undertreating (free for a limited period)

 


Chlamydia and gonorrhea: new recommendation to screen sexually active patients under 30

20 Apr, 2021 | 05:42h | UTC

Guideline: Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk – Canadian Medical Association Journal

News release: Under 30 and sexually active? It’s a good idea to get tested for chlamydia and gonorrhea – Canadian Task Force on Preventive Health Care

Summary: Chlamydia and gonorrhea: new recommendation to screen sexually active patients under 30 – Canadian Task Force on Preventive Health Care

Related USPSTF Draft Statement: Screening for Chlamydia and Gonorrhea – U.S. Preventive Services Task Force

 


AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk

30 Mar, 2021 | 03:08h | UTC

Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association – Circulation

News Release: Six pregnancy complications are among red flags for heart disease later in life – American Heart Association

 


Covid-19: Middle aged women face greater risk of debilitating long term symptoms

28 Mar, 2021 | 22:49h | UTC

Covid-19: Middle aged women face greater risk of debilitating long term symptoms – The BMJ

Linked Opinion: The stigma is real for people living with long covid – The BMJ Opinion

 


Special Issue: The importance of women’s health in peri‐operative care

16 Mar, 2021 | 01:42h | UTC

Special Issue: The importance of women’s health in peri‐operative care – Anaesthesia

 


Cohort study: Hypertensive disorders of pregnancy linked to subsequent risk of premature mortality

10 Mar, 2021 | 08:24h | UTC

Hypertensive Disorders of Pregnancy and Subsequent Risk of Premature Mortality – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentaries: Do Hypertension Disorders of Pregnancy Increase Risk of Premature Maternal Mortality? – American College of Cardiology AND Hypertension disorders of pregnancy increase risk of premature maternal mortality – American College of Cardiology

 


WHO Report | Devastatingly pervasive: 1 in 3 women globally experience violence

10 Mar, 2021 | 08:21h | UTC

Devastatingly pervasive: 1 in 3 women globally experience violence – World Health Organization

Commentary: Violence Against Women Is “Unequivocally Pervasive”, Reveals Largest WHO Study Ever – Health Policy Watch

 


RCT: Secondary cytoreduction followed by chemotherapy vs. chemotherapy alone in platinum-sensitive relapsed ovarian cancer

10 Mar, 2021 | 08:18h | UTC

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

11 Mar, 2021 | 08:35h | UTC

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk – Association of Anaesthetists of Great Britain and Ireland

Original study: Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study – Anaesthesia

 

Commentary on Twitter

 


Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance

5 Mar, 2021 | 08:35h | UTC

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance – The BMJ

Recommendations: Pharmacovigilance Evidence Review: The effect of COVID-19 vaccines on breast screening – Drug Safety Research Unit

Related: 2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients

 


USPSTF Draft Statement: Screening for Chlamydia and Gonorrhea in Sexually Active Women

3 Mar, 2021 | 08:43h | UTC

Screening for Chlamydia and Gonorrhea – U.S. Preventive Services Task Force

 


ACOG Committee Opinion: Health care for transgender and gender diverse individuals

3 Mar, 2021 | 08:41h | UTC

Health Care for Transgender and Gender Diverse Individuals – Obstetrics & Gynecology

Summary: Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion Summary – Obstetrics & Gynecology

 


RCT: Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years

26 Feb, 2021 | 08:34h | UTC

Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai – The BMJ

Commentaries: The story of the Mumbai breast screening study – The BMJ Opinion

 

 


RCT: Treatment of uterine fibroid symptoms with Relugolix combination therapy

19 Feb, 2021 | 02:08h | UTC

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy – New England Journal of Medicine

 


RCT: Levonorgestrel-releasing intrauterine system vs. endometrial ablation for heavy menstrual bleeding

18 Feb, 2021 | 02:38h | UTC

Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding – American Journal of Obstetrics & Gynecology

 


Cost-effective analysis suggests incorporating baseline breast density at 40 years to determine the frequency of screening in women at average risk for breast cancer

10 Feb, 2021 | 01:37h | UTC

Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer: A Cost-Effectiveness Analysis – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentaries: Screening based on breast density at age 40 may reduce breast cancer mortality – ACP Internist AND Screening strategy based on baseline breast density at age 40 may be effective for reducing breast cancer mortality – American College of Physicians AND For Mammography: Baseline at 40 Makes Sense – Diagnostic Imaging

 

Commentary on Twitter

 


Consensus statement: Cardiovascular health after menopause transition, pregnancy disorders, and other gynecologic conditions

10 Feb, 2021 | 01:25h | UTC

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists – European Heart Journal

Commentary: ESC Consensus Document Provides Guidance on CV Risk in Women After Menopause, Pregnancy Disorders, Gynecologic Conditions – American College of Cardiology

 

Commentary on Twitter

 


Randomized trial: Levonorgestrel vs. copper intrauterine devices for emergency contraception

28 Jan, 2021 | 01:27h | UTC

Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception – New England Journal of Medicine

Visual abstract: Levonorgestrel vs. Copper IUDs for Emergency Contraception

 


Stay Updated in Your Specialty

No spam, just news.